Levosimendan Improves Renal Function in Acute Decompensated Heart Failure: Cause and Clinical Application
- 20 November 2007
- journal article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 21 (6) , 403-404
- https://doi.org/10.1007/s10557-007-6070-y
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Levosimendan Improves Renal Function in Patients with Acute Decompensated Heart Failure: Comparison with DobutamineCardiovascular Drugs and Therapy, 2007
- Worsening Renal Function and Prognosis in Heart Failure: Systematic Review and Meta-AnalysisJournal of Cardiac Failure, 2007
- Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunctionEuropean Journal of Heart Failure, 2007
- Levosimendan Improves Renal Function in Patients With Advanced Chronic Heart Failure Awaiting Cardiac TransplantationJournal of Cardiac Failure, 2007
- High Prevalence of Renal Dysfunction and Its Impact on Outcome in 118,465 Patients Hospitalized With Acute Decompensated Heart Failure: A Report From the ADHERE DatabaseJournal of Cardiac Failure, 2007
- Classical inotropes and new cardiac enhancersHeart Failure Reviews, 2007
- Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart FailureJAMA, 2007
- Clinical trials update from the American Heart Association: REPAIR‐AMI, ASTAMI, JELIS, MEGA, REVIVE‐II, SURVIVE, and PROACTIVEEuropean Journal of Heart Failure, 2005
- Role of Diminished Renal Function in Cardiovascular MortalityJournal of the American College of Cardiology, 2005
- Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trialThe Lancet, 2002